Investor Kit

Company Profile

Founded in 1995, Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.

Acorda has an industry leading pipeline of novel neurological therapies addressing a range of disorders, including Parkinson’s disease, post-stroke walking difficulty, migraine, and multiple sclerosis. Acorda markets three FDA-approved therapies, including AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg.

Stock Chart

Financials

Date Filing Description Download
05/20/16 8-K Current report filing
05/16/16 4 Statement of Changes in Beneficial Ownership
05/13/16 4 Statement of Changes in Beneficial Ownership
05/13/16 4 Statement of Changes in Beneficial Ownership

Stock Quote

ACOR (Common Stock) $ 27.21 -0.38 (-1.38%) Volume: 425,892 MORE May 25, 2016

Email Alerts

Un-subscribe from email alerts
Email Address *
Mailing Lists *





 
Enter the code shown above.